Remove 2026 Remove Networking Remove Pharma
article thumbnail

CPHI Pharma Awards 2023 finalists announced

European Pharmaceutical Review

For its 20 th anniversary, more than 180 entries across 12 categories have been narrowed down to determine the finalists the upcoming CPHI Pharma Awards. Award winners will be revealed at a networking reception on the first day of CPHI Barcelona 2023, which is running from 24-26 October. Are you coming to the CPHI Barcelona 2023?

Pharma 119
article thumbnail

Sandoz to build biologics plant in Slovenia

European Pharmaceutical Review

Full operations is provisionally planned for late 2026. The company also recently announced an additional €50 million investment to expand its European-based antibiotics production network. This brings the total new investment commitment to the network in the past few years to €250 million.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Key Developments from AMCP 2023 on Blockbuster Generics, Diabetes Drugs, PBM Legislation, and More

PM360

The product, manufactured by ARS Pharma and Neurelis Pharma, would be the first needle-free epinephrine alternative to autoinjectors, such as the EpiPen. Starting in 2026, the provision will affect 10 Part D drugs. Still, the law may impact claim operations and network contracts, Casberg noted.

article thumbnail

U.S. market access landscape: A push for control is erasing the boundary between payers and providers in U.S. healthcare

Clarivate

Oak Street has 169 locations across 21 states and expects to nearly double its size to 300 centers by 2026. Lines are blurring between payers and providers More and more, large integrated delivery networks and national payers are battling each other for greater control over patient costs and outcomes.

article thumbnail

A Look Into Telehealth in 2021 and Beyond

Pharma Marketing Network

Billion by 2026 with a CAGR of 37.2% The post A Look Into Telehealth in 2021 and Beyond appeared first on Pharma Marketing Network. According to a stat by Medgadget, “Global Telemedicine Market is valued at USD 27.04 Billion in 2019 and Expected to Reach USD 171.81 over the Forecast Period.”.

article thumbnail

New €300m Angelini Ventures fund combines venture creation and direct investments to pave the way for healthcare transformation

pharmaphorum

Angelini Ventures will lend its network and knowledge of the life sciences industry to “strengthen the bridge between the excellence of Italian academic research and the development of drug discovery programmes in order to identify new treatment options,” said Angelini Industries CEO Professor Sergio Marullo di Condojanni in a statement.

article thumbnail

Inflationary storm clouds will continue to buffet global pharma industry in 2023

Pharmaceutical Technology

Pharma may have to navigate a difficult path through relatively slow-to-fall inflation in regions outside the US. Negotiated prices will not apply until 2026, but the selected medicines for Medicare price negotiations will be unveiled in September 2023. The entire pharma industry will be affected by the fallout. Free Report.

Pharma 64